Image of Hugo Stolkin

Hugo Stolkin

Corporate M&A Partner, London

"Hugo is an English Corporate M&A Partner. He advises the boards and senior management of corporations and banks on cross-border mergers and acquisitions, listings and governance and compliance matters."

Overview

Professional experience

Overview

Hugo has extensive experience in the London market and internationally across a range of sectors, including tech, fin tech, pharmaceuticals, food & beverages, energy, and natural resources. Currently based in London, Hugo has spent several years working in Linklaters offices in Eastern Europe and South East Asia and his experience includes advising on transactions and governance matters in the Former Soviet Union, Central and South East Asia, China and Africa.

Work highlights

  • Vodafone and a consortium of international telecoms companies on their US$200m aggregated API technology joint venture with Ericsson
  • CK Hutchison on the £15bn merger of Vodafone UK and Three UK
  • US-based Patterson UTI (PTEN) on its unconventional oilfield drilling joint venture with ADNOC and Schlumberger
  • EVRAZ plc, a FTSE 100 steel and mining company, in relation to the demerger of its coal business, PAO Raspadskaya;
  • The owners of Navig8 Limited on the plus US$1bn sale of a shipping tanker business to ADNOC
  • Switzerland’s SIX Group on its acquisition of the Ultumus cross-border indexation data business
  • Greece’s Eurobank on the sale of its payment services business to Worldline
  • Euroclear SA/NV on its €500m acquisition of 100% of the shares of MFEX Holding AB, the holding company for MFEX group, from Nordic Capital
  • Nexi on its €8bn payment services merger with Nets
  • Switzerland’s SIX Group on the CHF3bn disposal of SIX Payment Services to France’s Worldline

Professional experience

Further deals

  • Dutch and South African listed Prosus on the €2.5bn disposal of its Russian e-classified business
  • Heineken on the sale of its Russian business
  • China’s Jingye on the acquisition of British Steel
  • Bayer AG on the £1bn acquisition of KaNDy Therapeutics